AFLD proposes more testing for Armstrong samples

"For the sake of objectivity and justice, and to enable the cyclist Lance Armstrong dispel any unfounded rumors", the French Anti-Doping Agency (AFLD) proposed Wednesday to offer for analysis six of Armstrong's residual urine samples (B samples) taken during the 1999 Tour de France.

The Agency suggested testing the samples for recombinant EPO. Despite the elapsed nine years, at least five of the samples are considered by the AFLD to be in suitable condition and of sufficient volume to permit such testing. The samples were preserved at the French National Anti-Doping Lab (LNDD) following a January 4, 2006, court tribunal defamation decision involving Armstrong.

Laura Weislo
Managing Editor

Laura Weislo has been with Cyclingnews since 2006 after making a switch from a career in science. As Managing Editor, she coordinates coverage for North American events and global news. As former elite-level road racer who dabbled in cyclo-cross and track, Laura has a passion for all three disciplines. When not working she likes to go camping and explore lesser traveled roads, paths and gravel tracks. Laura specialises in covering doping, anti-doping, UCI governance and performing data analysis.